We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPXC
601
DELISTED
RPX Corporation
RPXC
-763,117
Closed -$9.16M
MULE
602
DELISTED
MuleSoft, Inc.
MULE
-75,000
Closed -$1.82M
SRUNU
603
DELISTED
Silver Run Acquisition Corporation II Units
SRUNU
-5,000,000
Closed -$52.1M
BIOA
604
CALL
DELISTED
BioAmber Inc.
BIOA
-135,649
Closed -$315K
BWLD
605
DELISTED
Buffalo Wild Wings, Inc.
BWLD
-91,856
Closed -$14M
TIME
606
DELISTED
Time Inc.
TIME
-523,898
Closed -$10.1M
SYT
607
DELISTED
Syngenta Ag
SYT
-1,200,000
Closed -$106M
POT
608
DELISTED
Potash Corp Of Saskatchewan
POT
-955,017
Closed -$16.3M
ABCO
609
DELISTED
Advisory Board Co
ABCO
-262,625
Closed -$12.3M
CCP
610
DELISTED
Care Capital Properties, Inc.
CCP
-71,692
Closed -$1.93M
SNOW
611
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
-439,005
Closed -$11M
INNL
612
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
-489,155
Closed -$548K
KCG
613
DELISTED
KCG Holdings, Inc.
KCG
-225,000
Closed -$4.01M
CPAAU
614
DELISTED
Conyers Park Acquisition Corp. Unit
CPAAU
-1,200,000
Closed -$13.5M
CLAC
615
CALL
DELISTED
Capitol Acquisition Corp. III
CLAC
-500,000
Closed -$5.28M
CLAC
616
DELISTED
Capitol Acquisition Corp. III
CLAC
-1,000,000
Closed -$10.6M
PVTB
617
DELISTED
PrivateBancorp Inc
PVTB
-1,000,000
Closed -$59.4M
VAL
618
DELISTED
Valspar
VAL
-557,868
Closed -$61.9M
WINT
619
CALL
DELISTED
Windtree Therapeutics Inc
WINT
-680,570
Closed -$776K
WINT
620
DELISTED
Windtree Therapeutics Inc
WINT
-459,364
Closed -$524K
SWC
621
DELISTED
Stillwater Mining Co
SWC
-1,000,000
Closed -$17.3M
NMBL
622
DELISTED
Nimble Storage, Inc.
NMBL
-860,263
Closed -$10.8M
BEAV
623
DELISTED
B/E Aerospace Inc
BEAV
-1,641,272
Closed -$105M
ESV
624
DELISTED
Ensco Rowan plc
ESV
-1,221,060
Closed -$43.7M
IMDZ
625
DELISTED
Immune Design Corp.
IMDZ
-165,545
Closed -$1.13M

Similar funds

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.